EAA173 Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)

January 19, 2021
https://ci-hap-org.mtdev.site/sitecore/shell/Applications/Content%20Editor.aspx?sc_bw=1
Cancer - Myeloma
Principal Investigator: Ding Wang, MD
CANCER, BLOOD, BLOOD CANCER, MYELOMA, SMOLDERING
Accepting Participants